HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats.

Abstract
T-1095, a derivative of phlorizin, is an orally active inhibitor of Na+-glucose cotransporter (SGLT). We investigated the acute antihyperglycemic effect of T-1095 in streptozotocin-induced diabetic rats (STZ rats). T-1095 and its metabolite T-1095A inhibited the SGLT activity in brush border membranes prepared from kidneys of both normal and STZ rats, but the latter agent was approximately 10 times more potent than the former. Single oral administration of T-1095 (30-100 mg/kg) dose-dependently induced glycosuria in normal rats. The fed glucose levels in STZ rats were dose-dependently suppressed by single oral administration of T-1095 (3-100 mg/kg), whereas there was only marginal hypoglycemic effect in normal rats. Since there was no effect on blood glucose in nephrectomized STZ rats, inhibition of renal glucose reabsorption rather than intestinal glucose absorption mainly contributes to the antihyperglycemic effect of T-1095. In conclusion, T-1095 is the first orally active agent which has an acute antihyperglycemic action in the absence of endogenous insulin secretion with a low risk of hypoglycemia and has therapeutic potential for treatment of diabetes mellitus.
AuthorsA Oku, K Ueta, K Arakawa, T Kano-Ishihara, M Matsumoto, T Adachi, K Yasuda, K Tsuda, A Saito
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 23 Issue 12 Pg. 1434-7 (Dec 2000) ISSN: 0918-6158 [Print] Japan
PMID11145172 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Carbonates
  • Glucosides
  • Hypoglycemic Agents
  • Monosaccharide Transport Proteins
  • T 1095
Topics
  • Animals
  • Blood Glucose (drug effects)
  • Carbonates (pharmacology)
  • Diabetes Mellitus, Experimental (blood, drug therapy, urine)
  • Glucosides (pharmacology)
  • Glycosuria (urine)
  • Hyperglycemia (blood, drug therapy, urine)
  • Hypoglycemic Agents (pharmacology)
  • Kidney (drug effects, metabolism, ultrastructure)
  • Male
  • Microvilli (drug effects, metabolism)
  • Monosaccharide Transport Proteins (antagonists & inhibitors)
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: